EUVIMEDEUVIMED entdecken
Crossref

Individual differences in in vitro and in vivo metabolic clearances of the antipsychotic drug olanzapine from non‐smoking and smoking Japanese subjects genotyped for cytochrome P4502D6 and flavincontaining monooxygenase 3

Maho Okubo, Momoko Narita, Norie Murayama, Youichi Akimoto, Akiko Goto, Hiroshi Yamazaki

Human Psychopharmacology: Clinical and Experimental · 2016-03 · 31 (2) · 83-92

DOI: 10.1002/hup.2515 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Psychopharmacology: Clinical and Experimental, online erschienen am 08.02.2016. Verfasst von Maho Okubo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo, Japan. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The antipsychotic olanzapine is reportedly metabolized by inducible human cytochrome P450 (CYP) 1A2 and variable copy‐number CYP2D6 and polymorphic flavin‐containing monooxygenase 3 (FMO3) in different pathways. We investigated individual differences in the metabolite formation and clearance of olanzapine in vitro and in vivo .

Methods

Human liver microsomal olanzapine oxidation activities were evaluated, and plasma concentrations of olanzapine were determined in 21 Japanese patients (mean age: 50 years, range: 32–69 years, 14 male and 7 female, including 6 smokers) genotyped for CYP2D6 ( *1 , *5 , and *10 ) and FMO3 (E158K, C197fsX, R205C, V257M, E308G, and R500X).

Results

Furafylline (a CYP1A2 inhibitor), quinidine (a CYP2D6 inhibitor), and heat treatment (inactivates FMO3) suppressed liver microsomal metabolic clearance of olanzapine by approximately 30%. Olanzapine N ‐demethylation and N ‐oxygenation were found to be catalyzed by CYP1A2 and CYP2D6 and by CYP2D6 and FMO3, respectively, in experiments using liver microsomes and recombinant enzymes. Plasma concentrations and clearance of olanzapine were not affected by CYP2D6 or FMO3 genotypes or smoking behavior.

Conclusions

Olanzapine clearance was not affected by CYP2D6 or FMO3 genotypes or smoking behavior as a single factor under the present conditions because olanzapine clearance is mediated by multiple enzymes involved in two major and one minor pathways. Copyright © 2016 John Wiley & Sons, Ltd.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAgedAntipsychotic AgentsAsian PeopleBenzodiazepinesCytochrome P-450 CYP1A2Cytochrome P-450 CYP2D6FemaleGenotyping TechniquesHumansJapanMaleMicrosomes, LiverMiddle AgedMolecular StructureOlanzapineOxygenasesRecombinant ProteinsSmoking

Stichwörter der Autor:innen

CYP1A2CYP2D6FMO3Japaneseclearanceolanzapine

Substanzen

Antipsychotic AgentsRecombinant ProteinsBenzodiazepinesOxygenasesdimethylaniline monooxygenase (N-oxide forming)CYP1A2 protein, humanCytochrome P-450 CYP1A2Cytochrome P-450 CYP2D6Olanzapine

Autor:innen und Institutionen

  • Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo, Japan.
  • Tsurugaoka Garden Hospital, Machida, Tokyo, Japan.

Förderung

  • JSPS KAKENHI

Zitieren

APA

Okubo, M., Narita, M., Murayama, N., Akimoto, Y., Goto, A., & Yamazaki, H. (2016). Individual differences in in vitro and in vivo metabolic clearances of the antipsychotic drug olanzapine from non‐smoking and smoking Japanese subjects genotyped for cytochrome P4502D6 and flavincontaining monooxygenase 3. Human Psychopharmacology: Clinical and Experimental, 31(2), 83-92. https://doi.org/10.1002/hup.2515

Vancouver

Okubo M, Narita M, Murayama N, Akimoto Y, Goto A, Yamazaki H. Individual differences in in vitro and in vivo metabolic clearances of the antipsychotic drug olanzapine from non‐smoking and smoking Japanese subjects genotyped for cytochrome P4502D6 and flavincontaining monooxygenase 3. Human Psychopharmacology: Clinical and Experimental. 2016;31(2):83-92. doi:10.1002/hup.2515

BibTeX
@article{Okubo2016,
  author = {Okubo, Maho and Narita, Momoko and Murayama, Norie and Akimoto, Youichi and Goto, Akiko and Yamazaki, Hiroshi},
  title = {Individual differences in in vitro and in vivo metabolic clearances of the antipsychotic drug olanzapine from non‐smoking and smoking Japanese subjects genotyped for cytochrome P4502D6 and flavincontaining monooxygenase 3},
  journal = {Human Psychopharmacology: Clinical and Experimental},
  year = {2016},
  volume = {31},
  number = {2},
  pages = {83--92},
  doi = {10.1002/hup.2515}
}
Kostenlos starten →